Table 1: Sex and age distribution of the two studied groups &endash; patients with MS and Other Neurological Diseases. |
||||
Survey Demographics |
||||
MS |
OND |
|||
Age |
Males |
Females |
Males |
Females |
<14 |
0 |
0 |
1 |
1 |
15-24 |
1 |
4 |
11 |
21 |
25-34 |
12 |
43 |
32 |
45 |
35-44 |
27 |
147 |
39 |
70 |
45-54 |
74 |
137 |
62 |
48 |
55-64 |
32 |
79 |
45 |
52 |
65-74 |
20 |
41 |
53 |
48 |
>75 |
5 |
12 |
51 |
37 |
TOTAL |
171 |
462 |
294 |
322 |
mean +/- sd |
51.3+/-11.5 |
48.1+/-12.1 |
55.2+/-17.6 |
50.6+/-17.9 |
Back to Herpes Zoster and Multiple Sclerosis
Table 2: Comparison of the rates of herpes zoster (HZ) in a group of patients with multiple sclerosis (MS), a practice-based survey without reference to any other disease, and a group of patients with other neurological diseases. |
||||||||
Comparison of Rates of Herpes Zoster in Four Groups |
||||||||
Multiple Sclerosis Patients |
Practice-based Survey 8 |
Other Neurological Diseases |
||||||
Positive history HZ |
N192/3534 = 5.4% |
N42/616 = 6.8% |
||||||
Positive & Probable |
||||||||
|
Back to Herpes Zoster and Multiple Sclerosis
Table 3A: Number of multiple sclerosis patients with herpes zoster and age of onset of herpes zoster in this study (observed) compared to the number from a population-based study9 (expected). Numbers in parentheses are patients with herpes zoster prior to the diagnosis of multiple sclerosis. *The total observed number, 68, is less than the actual number, 72, as four patients omitted their ages at the time of the herpes zoster. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Multiple Sclerosis Patients Observed to have Herpes Zoster Versus the Expected Number |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Back to Herpes Zoster and Multiple Sclerosis
Table 3B: The proportion of multiple sclerosis patients in this study (N 633) related to their sex and age of onset of herpes zoster compared to control patients (N 616). |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Age of Onset of Herpes Zoster in a Group of Patients with Multiple Sclerosis and Other Neurological Diseases |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|